Project Number 1R21AG063012-01A1 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Targeting Caspase-2 in Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 8. Cell Death a. Apoptosis Researcher and Organization Principal Investigator SHELANSKI, MICHAEL L Principal Investigator First Name MICHAEL L Principal Investigator Last Name SHELANSKI Awardee Organization COLUMBIA UNIVERSITY Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PA-19-053: NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) FY Overall Cost $202,500 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official OPANASHUK, LISA A
